skip to main content

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


Title: Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique

Persons living with human immunodeficiency virus (HIV) have a disproportionately higher burden of human papillomavirus infection (HPV)-related cancers. Causal factors include both behavioral and biological. While pharmaceutical and care support interventions help address biological risk of coinfection, as social conditions are common drivers of behaviors, structural interventions are key part of behavioral interventions. Our objective is to develop a joint HIV-HPV model to evaluate the contribution of each factor, to subsequently inform intervention analyses. While compartmental modeling is sufficient for faster spreading HPV, network modeling is suitable for slower spreading HIV. However, using network modeling for jointly modeling HIV and HPV can generate computational complexities given their vastly varying disease epidemiology and disease burden across sub-population groups. We applied a recently developed mixed agent-based compartmental (MAC) simulation technique, which simulates persons with at least one slower spreading disease and their immediate contacts as agents in a network, and all other persons including those with faster spreading diseases in a compartmental model, with an evolving contact network algorithm maintaining the dynamics between the two models. We simulated HIV and HPV in the U.S. among heterosexual female, heterosexual male, and men who have sex with men (men only and men and women) (MSM), sub-populations that mix but have varying HIV burden, and cervical cancer among women. We conducted numerical analyses to evaluate the contribution of behavioral and biological factors to risk of cervical cancer among women with HIV. The model outputs for HIV, HPV, and cervical cancer compared well with surveillance estimates. Model estimates for relative prevalence of HPV (1.67 times) and relative incidence of cervical cancer (3.6 times), among women with HIV compared to women without, were also similar to that reported in observational studies in the literature. The fraction attributed to biological factors ranged from 22–38% for increased HPV prevalence and 80% for increased cervical cancer incidence, the remaining attributed to behavioral. The attribution of both behavioral and biological factors to increased HPV prevalence and cervical cancer incidence suggest the need for behavioral, structural, and pharmaceutical interventions. Validity of model results related to both individual and joint disease metrics serves as proof-of-concept of the MAC simulation technique. Understanding the contribution of behavioral and biological factors of risk helps inform interventions. Future work can expand the model to simulate sexual and care behaviors as functions of social conditions to jointly evaluate behavioral, structural, and pharmaceutical interventions for HIV and cervical cancer prevention.

  more » « less
Award ID(s):
1915481
PAR ID:
10478702
Author(s) / Creator(s):
;
Editor(s):
Kolawole, Olatunji Matthew
Publisher / Repository:
PLOS
Date Published:
Journal Name:
PLOS ONE
Volume:
18
Issue:
11
ISSN:
1932-6203
Page Range / eLocation ID:
e0288141
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ( , Clinical Cancer Research)
    Abstract

    Introduction: To counteract the rapidly increasing incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC), development of effective biomarkers and other novel screening strategies are necessary to effectively detect early disease in well-defined high-risk populations. The most promising biomarkers are circulating tumor HPV DNA (ctHPV), antibodies (Abs) to HPV16 early (E) antigens, and persistent infection with oral oncogenic HPV. Here, we report the prevalence of ctHPV in a population of middle-aged men, a group with high OPC incidence, and evaluate concordance between the three HPV biomarkers. Materials and Methods: We included participants enrolled in the HPV-related Oropharyngeal and Uncommon Cancers Screening Trial of Men (HOUSTON) study between April 2017 and December 2019. The HOUSTON study was designed to evaluate biomarkers and novel screening strategies for HPV-related cancers among middle-aged men (50-64 years), the group with the highest incidence of HPV-related OPC. We tested plasma for ctHPV using a digital droplet polymerase chain reaction (ddPCR) assay (NavDx, Naveris, Waltham, MA). We previously tested the plasma from these participants for HPV16 E Abs using a novel RAPID ELISA and for prevalent oral HPV16 (oHPV16) infection in oral rinse using the cobas HPV Test (Roche Diagnostics, Indianapolis, IN). We used Fisher’s exact test to determine statistical significance for the association between biomarkers (alpha < 0.05). Results: Of 345 samples tested, 343 were adequate for ctHPV analysis. Of these, 314 were negative (92.4%) and two were positive (0.6%; both for HPV16). Twenty-four had an indeterminate (Ind) result (7.0%), meaning ctHPV levels fell outside the established parameters for a negative or positive results. All three markers were available for 340 samples with the following results: ctHPV+/Ab+/oHPV16+: 1 (0.3%); ctHPV+/Ab-/oHPV16-: 1 (0.3%); ctHPV Ind/Ab-/oHPV16+: 3 (0.9%); ctHPV Ind/Ab-/oHPV16-: 21 (6.2%); ctHPV-/Ab+/oHPV16+: 1 (0.3%); ctHPV-/Ab+/oHPV16-: 3 (0.9%); ctHPV-/Ab-/oHPV16+: 16 (4.7%); ctHPV-/Ab-/oHPV16-: 294 (86.5%); all other combinations had no observations. ctHPV was associated with HPV16 E Abs and oHPV16 status individually and combined (individually, p = 0.032 for both and combined, p = 0.025). A ctHPV-/Ab+/oHPV16-man was diagnosed with an anal low-grade squamous intraepithelial lesion and was persistently high-risk HPV-positive at the right tonsil/base of tongue. One man was positive for all three markers and was subsequently diagnosed with stage II (T1N1) HPV16-positive/Epstein-Barr-negative nasopharyngeal cancer four months following study enrollment. Conclusions: ctHPV was rare in a general population of middle-aged men. Our results suggest that these markers in combination may be able to correctly identify early HPV-related cancers. Larger studies are needed to confirm this finding. The authors accept sole responsibility for the statements in this abstract.

    Citation Format: Kristina R. Dahlstrom, Karen S. Anderson, Erich M. Sturgis. Biomarkers for early diagnosis of human papillomavirus-related oropharyngeal cancer [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-037.

     
    more » « less
  2. ; ; ; ; ; ; ; ; ; ; et al ( , Frontiers in Public Health)
    Background

    Cancer remains a major public health problem, especially in Sub-Saharan Africa (SSA) where the provision of health care is poor. This scoping review mapped evidence in the literature regarding the burden of cervical, breast and prostate cancers in SSA.

     Methods

    We conducted this scoping review using the Arksey and O'Malley framework, with five steps: identifying the research question; searching for relevant studies; selecting studies; charting the data; and collating, summarizing, and reporting the data. We performed all the steps independently and resolved disagreements through discussion. We used Endnote software to manage references and the Rayyan software to screen studies.

     Results

    We found 138 studies that met our inclusion criteria from 2,751 studies identified through the electronic databases. The majority were retrospective studies of mostly registries and patient files (n= 77, 55.8%), followed by cross-sectional studies (n= 51, 36.9%). We included studies published from 1990 to 2021, with a sharp increase from 2010 to 2021. The quality of studies was overall satisfactory. Most studies were done in South Africa (n= 20) and Nigeria (n= 17). The majority were on cervical cancer (n= 93, 67.4%), followed by breast cancer (67, 48.6%) and the least were on prostate cancer (48, 34.8%). Concerning the burden of cancer, most reported prevalence and incidence. We also found a few studies investigating mortality, disability-adjusted life years (DALYs), and years of life lost (YLL).

     Conclusions

    We found many retrospective record review cross-sectional studies, mainly in South Africa and Nigeria, reporting the prevalence and incidence of cervical, breast and prostate cancer in SSA. There were a few systematic and scoping reviews. There is a scarcity of cervical, breast and prostate cancer burden studies in several SSA countries. The findings in this study can inform policy on improving the public health systems and therefore reduce cancer incidence and mortality in SSA.

     
    more » « less
  3. ; ; ( , Sociology of Health & Illness)
    Abstract

    This article examines human papillomavirus (HPV) self‐sampling as an approach to cervical cancer prevention and the ways self‐sampling kits are promoted directly to consumers in the United States. Public health, biomedicine and health tech have increasingly imagined self‐sampling, which allows individuals to collect their own vaginal specimen, mail to a laboratory for testing and receive delivered results, as a component of cervical cancer prevention and sexual health promotion. This article examines the scientific and biomedical claims used to configure the problem in need of this solution and the ways persons, publics and markets are established. We analyse scientific literature, interviews with clinicians and other key actors, and websites of directly to consumers (DTC) companies. HPV self‐sampling is constructed as both a solution to inequities and gaps in cervical cancer screening and a solution to the wants and needs of those already engaged in self‐projects of body monitoring and risk reduction. These multidirectional biomedical tendencies also reveal how sexuality and sexual health and cervical cancer prevention and sexual health promotion are entangled objects. While we do not want to undermine the potential of HPV self‐sampling, we encourage a focus on equity and care and not commodified markets that reinforce notions of ‘good’ patients monitoring their health.

     
    more » « less
  4. ; ; ; ; ; ; ; ; ; ( , Scientific Reports)
    Abstract

    Accurate HPV genotyping is crucial in facilitating epidemiology studies, vaccine trials, and HPV-related cancer research. Contemporary HPV genotyping assays only detect < 25% of all known HPV genotypes and are not accurate for low-risk or mixed HPV genotypes. Current genomic HPV genotyping algorithms use a simple read-alignment and filtering strategy that has difficulty handling repeats and homology sequences. Therefore, we have developed an optimized expectation–maximization algorithm, designated HPV-EM, to address the ambiguities caused by repetitive sequencing reads. HPV-EM achieved 97–100% accuracy when benchmarked using cell line data and TCGA cervical cancer data. We also validated HPV-EM using DNA tiling data on an institutional cervical cancer cohort (96.5% accuracy). Using HPV-EM, we demonstrated HPV genotypic differences in recurrence and patient outcomes in cervical and head and neck cancers.

     
    more » « less
  5. ; ; ( , Mathematical Biosciences and Engineering)
    Sexually transmitted diseases (STDs) are detrimental to the health and economic well-being of society. Consequently, predicting outbreaks and identifying effective disease interventions through epidemiological tools, such as compartmental models, is of the utmost importance. Unfortunately, the ordinary differential equation compartmental models attributed to the work of Kermack and McKendrick require a duration of infection that follows the exponential or Erlang distribution, despite the biological invalidity of such assumptions. As these assumptions negatively impact the quality of predictions, alternative approaches are required that capture how the variability in the duration of infection affects the trajectory of disease and the evaluation of disease interventions. So, we apply a new family of ordinary differential equation compartmental models based on the quantity person-days of infection to predict the trajectory of disease. Importantly, this new family of models features non-exponential and non-Erlang duration of infection distributions without requiring more complex integral and integrodifferential equation compartmental model formulations. As proof of concept, we calibrate our model to recent trends of chlamydia incidence in the U.S. and utilize a novel duration of infection distribution that features periodic hazard rates. We then evaluate how increasing STD screening rates alter predictions of incidence and disability adjusted life-years over a five-year horizon. Our findings illustrate that our family of compartmental models provides a better fit to chlamydia incidence trends than traditional compartmental models, based on Akaike information criterion. They also show new asymptomatic and symptomatic infections of chlamydia peak over drastically different time frames and that increasing the annual STD screening rates from 35% to 40%-70% would annually avert 6.1-40.3 incidence while saving 1.68-11.14 disability adjusted life-years per 1000 people. This suggests increasing the STD screening rate in the U.S. would greatly aid in ongoing public health efforts to curtail the rising trends in preventable STDs. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Save / Share this Record
  • Send to Email